Vodafone's Q3 2025 earnings show growth in service revenue and EBITDAaL, indicating a positive outlook for the company in the ...

Bank of America analysts raised their price target on the stock after earnings, citing Palantir's edge in a crowded market.

Oppenheimer analyst Jason Helfstein maintained an Outperform rating and raised the price target from $215 to $225 on Jan. 30, 2025. This analyst has an accuracy rate of 80%. Scotiabank analyst Nat ...

Meta shares moved higher Tuesday after setting a record close yesterday, as investors bid up the stock in the aftermath of a solid quarterly earnings report and optimism about the company's AI-related ...

Moelis & Co (NYSE:MC) is set to release its Q4 2024 earnings on Feb 5, 2025. The consensus estimate for Q4 2024 revenue is ...

Telephone and Data Systems' Q4 2024 earnings are expected to show sequentially improved EPS and revenue. Read why I downgrade ...

Spire Inc (NYSE:SR) is set to release its Q1 2025 earnings on Feb 5, 2025. The consensus estimate for Q1 2025 revenue is $756 ...

Advanced Micro Devices’ (AMD) pre-market jump of nearly 2% on Tuesday reversed after Morgan Stanley lowered its price target ...

DA Davidson raised the firm’s price target on Caterpillar (CAT) to $357 from $350 and keeps a Neutral rating on the shares after its Q4 ...

In the fast-paced world of investing, staying ahead requires good ideas and timely decisions. This article highlights five ...

Sales slid 17% to $661.6 million, short of the average Wall Street target of $679.8 million, as per FactSet. Sales at its electrical unit slid 22% to $465.4 million. For the year ending in September, ...

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of its HPV vaccine, Gardasil, to reach $11 billion by 2030. The result: a 10% ...